K Odunsi Selected Research

Doxorubicin (Adriamycin)

1/2012	Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer.
7/2004	Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Odunsi Research Topics

Disease

13	Neoplasms (Cancer) 12/2021 - 08/2001
5	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 08/2001
3	Carcinoma (Carcinomatosis) 12/2014 - 01/2006
1	Hypersensitivity (Allergy) 01/2016
1	Melanoma (Melanoma, Malignant) 06/2015
1	Hypertension (High Blood Pressure) 01/2013
1	Endometrial Neoplasms (Endometrial Cancer) 01/2012
1	Carcinogenesis 07/2009
1	Residual Neoplasm 07/2009
1	Necrosis 10/2008
1	Ewing Sarcoma (Sarcoma, Ewing) 12/2006
1	Primitive Neuroectodermal Tumors (PNET) 12/2006
1	Neoplasm Metastasis (Metastasis) 01/2006
1	Serous Cystadenoma 01/2006
1	Missed Abortion 08/2005
1	Sarcoma (Soft Tissue Sarcoma) 07/2004
1	Postoperative Hemorrhage 01/2004
1	Uterine Cervical Dysplasia 01/2004
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2001
1	Papillomavirus Infections 10/2001
1	Lymphoma (Lymphomas) 08/2001

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 11/2017 - 01/2007
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 03/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012 - 07/2004
1	Cancer VaccinesIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 12/2021
1	VaccinesIBA 12/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2017
1	130-nm albumin-bound paclitaxelIBA 01/2016
1	Docetaxel (Taxotere)FDA Link 01/2016
1	Chemokine ReceptorsIBA 06/2015
1	Messenger RNA (mRNA)IBA 12/2014
1	Folate Receptor 1IBA 12/2014
1	Coloring Agents (Dyes)IBA 01/2013
1	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 01/2013
1	Photosensitizing Agents (Photosensitizers)IBA 01/2013
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2013
1	Hematoporphyrin DerivativeIBA 01/2013
1	Bevacizumab (Avastin)FDA Link 01/2013
1	QuartzIBA 01/2013
1	Carboplatin (JM8)FDA LinkGeneric 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Etoposide (VP 16)FDA LinkGeneric 01/2012
1	LigandsIBA 10/2008
1	AntibodiesIBA 12/2006
1	Monoclonal AntibodiesIBA 12/2006
1	Death-Associated Protein KinasesIBA 01/2006
1	DNA (Deoxyribonucleic Acid)IBA 01/2006
1	Proteins (Proteins, Gene)FDA Link 01/2006
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2006
1	Misoprostol (Cytotec)FDA LinkGeneric 08/2005
1	TabletsIBA 08/2005
1	Vincristine (Oncovin)FDA LinkGeneric 07/2004
1	Dacarbazine (DIC)FDA LinkGeneric 07/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2004
1	Hemostatics (Antihemorrhagics)IBA 01/2004
1	PlatinumIBA 03/2003
1	HLA-DRB1*04:01 antigenIBA 10/2001
1	TransferasesIBA 08/2001
1	Lactalbumin (alpha-Lactalbumin)IBA 08/2001
1	EnzymesIBA 08/2001
1	Uridine Diphosphate (UDP)IBA 08/2001

Therapy/Procedure

8	Therapeutics 12/2021 - 05/2005
4	Drug Therapy (Chemotherapy) 01/2013 - 03/2003
3	Immunotherapy 12/2021 - 06/2015
2	Lasers (Laser) 01/2013 - 01/2004
2	Adjuvant Chemotherapy 01/2012 - 07/2004
1	Photochemotherapy (Photodynamic Therapy) 01/2013
1	Intravaginal Administration 08/2005
1	Pelvic Exenteration 05/2005
1	CYVADIC protocol 07/2004
1	Gas Lasers 01/2004